1. Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients
- Author
-
Mehmet Burak Özen, İbrahim Halil Özdemir, Eda Özlek, Bekir Serhat Yıldız, Bülent Özlek, Ali Rıza Bilge, Nurullah Çetin, and Ramazan Gündüz
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Physiology ,Serum Albumin, Human ,Single Center ,Logistic regression ,Gastroenterology ,law.invention ,law ,Internal medicine ,Internal Medicine ,Humans ,Medicine ,Retrospective Studies ,biology ,business.industry ,C-reactive protein ,Albumin ,COVID-19 ,Retrospective cohort study ,General Medicine ,Prognosis ,Intensive care unit ,C-Reactive Protein ,Hypertension ,biology.protein ,business ,human activities ,Area under the roc curve - Abstract
OBJECTIVES: The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. METHODS: It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were compared. The cut-off value was determined as a mortality predictor. The effect of CAR on mortality was evaluated using Logistic Regression analysis. RESULTS: 281 patients were included in the study. Groups consisted of 135 (non-survivor) and 146 (survivor) patients. CAR was significantly higher in the non-survivor group (p
- Published
- 2021
- Full Text
- View/download PDF